FDAFDA · Food and drugs·Recall number D-1545-2020
Losartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ by Hetero Labs, Limited, Mahabubragar, India
Published September 2, 2020 · Recall initiated: August 6, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specification; complaint of bulging tablet
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Hetero Labs Limited (Unit V)
- Distributor
- Product was distributed to major wholesalers/distributors throughout the United States.
- Lot
- Batch # LOA19357A, exp. date 09/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.